Diffusion lung capacity for carbon monoxide correlates with HRCT findings in patients with diffuse parenchymal lung disease
Tóm tắt
Diffusion lung capacity for carbon monoxide correlates with HRCT findings in patients with diffuse parenchymal lung disease. Diffuse parenchymal lung diseases (DPLDs) affect the alveolar epithelium, pulmonary capillary endothelium, basement membrane, and perivascular and perilymphatic tissues. High-resolution computed tomography (HRCT) of the chest is the gold standard modality for diagnosing DPLD. Pulmonary function tests usually show a restrictive defect in spirometry. Single breath diffusion lung capacity for carbon monoxide (DLCO-SB) technique is used to assess the diffuse parenchymal lung diseases, as there is thickening of the alveolar membrane and diminished total lung capacity due to interstitial processes with severe decline in the transfer factor. The aim of this work was to correlate between Warrick’s HRCT fibrosis score and DLCO-SB in DPLD and to assess the possibility of using DLCO as an only tool to follow up DPLD to avoid repeated radiation exposure of the patients in HRCT chest (decrease need for radiological follow-up) or vice versa. This work recruited 89 patients over a period of 10 months duration, 74.2% of them were females. The Warrick’s score, ground-glass opacity, irregular pleural margin, subpleural cyst, honeycombing, and septal and subpleural lines were represented as 96.6%, 70.8%, 55.1%, 49.4%, and 48.3% respectively in HRCT of DPLD. Warrick’s score and its subscores (severity score, extent score, alveolitis score, and fibrosis score) were associated with a highly significant decrease in different pulmonary function indices (FVC, FEV1, TLC, and DLCO) with P value 0.001. A highly significant correlation between DLCO grades and total score grades was found with P value 0.001, and 86.8% of the patients with severe DLCO affection showed severe degree of total fibrosis score. Both DLCO-SB and HRCT fibrosis scores were significantly correlated. Lifelong follow-up of function and structure of the lung in DPLD is needed by HRCT and DLCO. In an attempt to minimize repeated radiation exposure and reduce cost, we suggest DLCO to be used alone for longer follow-up periods rather than HRCT chest.
Tài liệu tham khảo
Putman K, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M et al (2016) Association between interstitial lung abnormalities and all-cause mortality. JAMA 315:672–681
Wells U, Kokosi A (2016) Subclinical interstitial lung abnormalities: toward the early detection of idiopathic pulmonary fibrosis? Am J Respir Crit Care Med 194:1445–1446
Oldham M, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L et al (2016) Characterisation of patients with interstitial pneumonia with autoimmune features. Eur Respir J 47:1767–1177
Sverzellati N, Desai S (2017) Radiology in diffuse parenchymal lung disease and lung nodules. Eur Respir Rev 26(144). https://doi.org/10.1183/16000617.0049-2017
Hansell D, Bankier A, MacMahon H, McLoud C, Müller N, Remy J (2008) Glossary of terms for thoracic imaging. Radiology 246:697–722
Riad N, Morshedy N, Shoukri A (2015) Role of pulmonary function tests in screening pulmonary arterial hypertension in scleroderma. Egypt J Bronchol 9:287–292
Warrick J, Bhalla M, Schabel S, Silver R (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18:1520–1528
Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Ruggiero A et al (2006) Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol 35:388–394
Khanna D, Tseng H, Farmani N, Steen V, Furst E, Clements J, Roth D et al (2011) Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum 63:3078–3085
Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM (1986) A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 133:97–103
Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al (2005) Standardization of spirometry American Thoracic Society/European Respiratory Society Task Force. Eur Respir J 26(2):319–338
Graham BL, Brusasco V, Burgos F, Brendan GC, Robert J, Adrian K et al (2017) Summary: 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 49(1):16
Abou Youssuf H, Sabry Y, Abd El-Hafeez A, Mohamed H (2016) Correlation between high-resolution computed tomography of the chest and pulmonary functions in idiopathic pulmonary fibrosis. Egypt J Bronchol 10:330–336
Raghu G, Collard H, Egan J, Martinez F, Behr J, Brown K et al (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183(6):788–824
Rifaat N, Anwar E, Ali Y, Hassan A (2014) Value of pulmonary rehabilitation in patients with IPF. Egypt J Chest Dis Tuberc 63:1013–1017
Hassan C (2018) Comparison of FVC, FVC/DLCO and Tlc/Dlco as an indicator for interstitial lung disease in patients with scleroderma. Chest 154(4):448
Kundu S, Mitra S, Ganguly J, Mukherjee S, Ray S, Mitra R (2014) Spectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: an eastern India experience. Lung India 31(4):354–360
Kheliouen A, Baough L, Mansouri B, Bendissari K, Zidouni N (2018) Etiological profile of an interstitial lung disease cohort in a Pulmonology Department of Algeria. EC Pulmonol Respir Med 7(7):488–499
Lv H, Liu J, Pan Q, Cai R, Zhang J (2019) Clinical retrospective analysis of interstitial lung disease patients associated with pulmonary hypertension. Med Sci Monit 25:7763–7769
Sánchez R, Fernández-Fabrellas E, Samper G, Montañana M, Vilar L (2018) Visual HRCT score to determine severity and prognosis of idiopathic pulmonary fibrosis. Int J Respir Pulm Med 5:84
Riad N, Salem H, Diab H (2014) Evaluation of diffusing capacity of the lung for carbon monoxide normalized per liter alveolar volume as a parameter for assessment of interstitial lung diseases. Egypt J Bronchol 8(1):51–56
Fessi R, Ourari B, Ben Amar J, Zaibi H, Azzabi S, Baccar M et al (2018) High-resolution computed tomography fibrosis score and pulmonary function tests in interstitial lung disease: is there any correlation? Eur Respir J 52(62):2926
Isaac B, Thangakunam B, Cherian R, Christopher D (2015) The correlation of symptoms, pulmonary function tests and exercise testing with high-resolution computed tomography in patients with idiopathic interstitial pneumonia in a tertiary care hospital in South India. Lung India 32(6):584–588
Michaelson E, Aguayo M, Roman J (2000) Idiopathic pulmonary fibrosis. A practical approach for diagnosis and management. Chest 118(3):788–794
Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Muller N, Schwartz DA et al (2003) Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 124(4):1215–1223
Sumikawa H, Johkoh T, Colby V, Ichikado K, Suga M, Taniguchi H et al (2008) Computed tomography findings in pathological usual interstitial pneumonia. Am J Respir Crit Care Med 177(4):433–439
Mura M, Ferretti A, Ferro O, Zompatori M, Cavalli A, Schiavina M et al (2006) Functional predictors of exertional dyspnea, 6-min walking distance and HRTC fibrosis score in idiopathic pulmonary fibrosis. Respiration 73(4):495–502
Hussein K, Shaaban L, Mohamed E (2016) Correlation of high resolution CT patterns with pulmonary function tests in patients with interstitial lung diseases. Egypt J Chest Dis Tuberc 65(3):681–688
Araki T, Nishino M, Gao W, Dupuis J, Putman R, Washko G et al (2015) Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance? Thorax 70(12):1156–1162
Leonel D, Lucia C, Muñiz A, Hernández M, Blanca M (2012) Pulmonary function test: its correlation with pulmonary high-resolution computed tomography in patients with rheumatoid arthritis. Rheumatol Int 32(7):2111–2116
Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H et al (2019) Baseline high-resolution CT findings predict acute exacerbation of idiopathic pulmonary fibrosis: German and Japanese Cohort Study. J Clin Med 8(12):2069
Lynch D, Godwin J, Safrin S, Starko K, Hormel P, Brown K et al (2005) Idiopathic Pulmonary Fibrosis Study Group: high-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 172(4):488–493